Full Text View
Tabular View
No Study Results Posted
Related Studies
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
This study is currently recruiting participants.
Verified July 2012 by Gilead Sciences
Study NCT01494987   Information provided by Gilead Sciences

First Received on December 15, 2011.   Last Updated on July 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Type 2 Diabetes Mellitus
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Ranolazine
Placebo
Additional drug interventions recognized in this trial
Glimepiride
More general drug interventions related to this trial
Anti-Arrhythmia Agents
Cardiovascular Agents
Enzyme Inhibitors
Hypoglycemic Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Gilead Sciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services